← Open Payments lookup

ALISON COLEMAN: Open Payments

NPI 1427500115 · BEAUMONT, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,098 in 93 payments from 20 companies in 2025. Trend: 2023 $1,657 · 2024 $1,655 · 2025 $2,098

Food & beverage: $1,964Education: $133
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP27$631
Regeneron Healthcare Solutions, Inc.8$241
Amgen Inc.6$133
Pharming Healthcare, Inc.6$130
Novartis Pharmaceuticals Corporation7$130
ARS Pharmaceuticals Operations, Inc.6$104
GENZYME CORPORATION4$96
CSL Behring4$94
Takeda Pharmaceuticals U.S.A., Inc.4$91
Genentech USA, Inc.3$81

Products named: DUPIXENT, TEZSPIRE, FASENRA, RUCONEST, NEFFY, AIRSUPRA, Xolair, Rhapsido.

Industry payments across TX — which companies pay providers there.